NewAmsterdam Pharma Co N.V. · Brief

Next report

4 days

Nov 4 · before openest.Q3 FY26

Expected move

±9.5%implied · report alone

18.1621.96

straddle ±13.7%

spot 20.06exp Nov 20ATM strike 20ATM straddle 3.22IV 83%

Oct 30 closereport share · term structure

Expected move

—≥ implied

Q2 FY26±12.6%▼−0.47%×0.04

quarterimplied−15%0+15%realized×

Q2 FY26±12.6%▼−0.47%×0.04

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 4 report · est.

—

NAMS report session

No linked exposure.

Oct 21impliedImplied move: ±12.9% into Nov 4 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.